Crown
CCK NYSE Paper & Plastic Packaging Products & Materials Financials FY2016βFY2025
Crown's revenue rose 4.8% to $12.4 billion in fiscal 2025. Its operating margin was 12.6%, up from 12.0% a year earlier. Free cash flow was $1.1 billion, up 41.6%. It paid out $625 million in dividends and buybacks, 56% of free cash flow. The diluted share count fell 3.1%.
What Crown does
No business description yet.
- Legal name
- CROWN HOLDINGS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-012904
0001219601
Revenue and margins
Crown had $12.4B of revenue in fiscal 2025, up 4.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 6.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 9.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Crown returned $625M to shareholders in fiscal 2025, 56% of free cash flow. The diluted share count fell 3.1%.
Value Crown yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$5.2B and divides by 115.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.9x Β· peers 16.6x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably Crown can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $531M | $550M | $1.3B | $918M | $764M |
| Debt incl. finance leases | $6.3B | $7.0B | $7.5B | $6.2B | $6.0B |
| Net debt / EBITDA | β | 3.6x | 3.5x | 2.8x | 2.6x |
| Debt / equity | 3.3x | 3.8x | 3.1x | 2.3x | 2.0x |
| Interest coverage | 5.4x | 4.7x | 2.9x | 3.1x | 3.9x |
| Current ratio | 1.1x | 1.2x | 1.2x | 1.2x | 1.0x |
| Quick ratio | 0.7x | 0.7x | 0.8x | 0.8x | 0.7x |
| Total assets | $13.9B | $14.3B | $15.0B | $13.8B | $14.3B |
| Total liabilities | $11.5B | $12.0B | $12.2B | $10.6B | $10.8B |
| Shareholders' equity | $1.9B | $1.8B | $2.4B | $2.8B | $3.0B |
| Net debt (β = net cash) | $5.7B | $6.4B | $6.2B | $5.3B | $5.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$16.5M
3 insiders
Of sales under plans
58%
$9.5M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 7,500 | $110.29 | $0.8M | Form 4 |
| Jun 23, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 15,000 | $105.00 | $1.6M | Form 4 |
| Apr 15, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 7,500 | $106.85 | $0.8M | Form 4 |
| Apr 8, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 7,500 | $105.00 | $0.8M | Form 4 |
| Feb 23, 2026 | Djalma Novaes JrEVP & COO | Sold | 29,734 | $114.80 | $3.4M | Form 4 |
| Feb 20, 2026 | Gerard H GiffordEVP & CAO | Sold | 13,373 | $113.98 | $1.5M | Form 4 |
| Feb 18, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 7,500 | $110.67 | $0.8M | Form 4 |
| Jan 29, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 7,500 | $105.00 | $0.8M | Form 4 |
| Jan 5, 2026 | Timothy J DonahuePresident & CEO, Director | Sold plan | 29,024 | $105.00 | $3.0M | Form 4 |
| Dec 18, 2025 | Timothy J DonahuePresident & CEO, Director | Sold plan | 8,476 | $105.01 | $0.9M | Form 4 |
| Dec 16, 2025 | Djalma Novaes JrEVP & COO | Sold | 19,754 | $101.02 | $2.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 8 | 6 / 8 | 7 / 8 |
| Accruals ratio | β6.8% | β5.3% | β5.6% |
| Altman Z'' | 1.84 | 2.21 | 2.00 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Crown CCK | $12.9B | 4.8% | 12.6% | 9.0% | 13.7% | 16.9x | 7 | |
| Packaging Corporation of America PKG | $22.0B | 7.2% | 12.3% | 8.1% | 11.8% | 32.1x | 4 | Compare β |
| Avery Dennison AVY | $13.9B | 1.1% | β | 8.0% | 14.6% | 19.9x | 5 | Compare β |
| Graphic Packaging GPK | $2.6B | β2.2% | 9.3% | β0.9% | 7.3% | 13.3x | 4 | Compare β |
| Sonoco SON | $5.0B | 41.7% | 13.5% | 4.6% | 9.4% | 4.9x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.3B | $8.7B | $11.2B | $11.7B | $9.4B | $11.4B | $12.9B | $12.0B | $11.8B | $12.4B |
| Research and development | $41.0M | $39.0M | $51.0M | $50.0M | $48.0M | $47.0M | $34.0M | $33.0M | $32.0M | $33.0M |
| Operating income | $997M | $1.0B | $1.1B | $1.0B | $1.0B | $1.4B | $1.3B | $1.3B | $1.4B | $1.6B |
| Interest expense | $243M | $252M | $384M | $367M | $290M | $253M | $284M | $436M | $452M | $398M |
| Pretax income | $769M | $829M | $740M | $631M | $725M | β$419M | $1.1B | $795M | $743M | $1.2B |
| Income tax | $186M | $401M | $216M | $136M | $199M | β$57.0M | $243M | $222M | $183M | $281M |
| Net income | $496M | $323M | $439M | $510M | $579M | β$560M | $727M | $450M | $424M | $738M |
| Diluted EPS | $3.56 | $2.38 | $3.28 | $3.78 | $4.30 | β$4.30 | $5.99 | $3.76 | $3.55 | $6.38 |
| Diluted shares | 0.14B | 0.14B | 0.13B | 0.13B | 0.13B | 0.13B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | β$134M | β$251M | $571M | $1.2B | $1.3B | $905M | $803M | $1.5B | $1.2B | $1.5B |
| Capital expenditure | $473M | $498M | $462M | $391M | $554M | $816M | $839M | $793M | $403M | $413M |
| Free cash flow | β$607M | β$749M | $109M | $772M | $761M | $89.0M | β$36.0M | $660M | $789M | $1.1B |
| Depreciation and amortization | β | β | β | β | β | β | $460M | $499M | $448M | $456M |
| Stock-based compensation | $20.0M | $23.0M | $27.0M | $29.0M | $32.0M | $33.0M | $29.0M | $31.0M | $42.0M | $48.0M |
| Acquisitions | $0.0M | $0.0M | $3.9B | $11.0M | $0.0M | $0.0M | $31.0M | $126M | $0.0M | $0.0M |
| Share buybacks | $8.0M | $339M | $4.0M | $7.0M | $66.0M | $950M | $722M | $12.0M | $217M | $505M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $105M | $106M | $115M | $119M | $120M |
| Dividends and buybacks | $8.0M | $339M | $4.0M | $7.0M | $66.0M | $1.1B | $828M | $127M | $336M | $625M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $559M | $424M | $607M | $607M | $1.2B | $531M | $550M | $1.3B | $918M | $764M |
| Total debt | $4.9B | $5.3B | $8.7B | $8.0B | $8.2B | $6.3B | $7.0B | $7.5B | $6.2B | $6.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $13.0M | $12.0M | $10.0M | $7.0M | $6.0M | $4.0M | $4.0M |
| Current assets | $2.8B | $3.1B | $4.1B | $4.0B | $4.9B | $4.5B | $4.7B | $4.8B | $4.2B | $4.4B |
| Current liabilities | $2.9B | $3.3B | $3.9B | $3.9B | $4.3B | $4.1B | $3.9B | $4.2B | $3.5B | $4.3B |
| Inventory | $1.2B | $1.4B | $1.7B | $1.6B | $1.3B | $1.7B | $2.0B | $1.6B | $1.4B | $1.6B |
| Property and equipment, net | $2.8B | $3.2B | $3.7B | $3.9B | $3.7B | $4.0B | $4.5B | $5.1B | $4.9B | $5.2B |
| Total assets | $9.6B | $10.7B | $15.3B | $12.7B | $16.7B | $13.9B | $14.3B | $15.0B | $13.8B | $14.3B |
| Total liabilities | $8.9B | $9.7B | $14.0B | $13.4B | $14.1B | $11.5B | $12.0B | $12.2B | $10.6B | $10.8B |
| Shareholders' equity | $366M | $601M | $937M | $1.7B | $2.2B | $1.9B | $1.8B | $2.4B | $2.8B | $3.0B |
| Margins | ||||||||||
| Operating margin | 12.0% | 11.8% | 9.8% | 8.8% | 11.2% | 12.0% | 10.3% | 10.6% | 12.0% | 12.6% |
| EBITDA margin | β | β | β | β | β | β | 13.9% | 14.7% | 15.8% | 16.3% |
| Net margin | 6.0% | 3.7% | 3.9% | 4.4% | 6.2% | β4.9% | 5.6% | 3.8% | 3.6% | 6.0% |
| FCF margin | β7.3% | β8.6% | 1.0% | 6.6% | 8.1% | 0.8% | β0.3% | 5.5% | 6.7% | 9.0% |
| Returns | ||||||||||
| Return on capital | 14.8% | 9.7% | 10.2% | 8.6% | 8.0% | 12.2% | 12.3% | 10.3% | 12.2% | 13.7% |
| Return on capital employed | 14.4% | 14.5% | 11.7% | 10.2% | 9.9% | 12.3% | 13.3% | 12.0% | 13.4% | 15.2% |
| Return on equity | β | β | 57.1% | 38.5% | 29.6% | β27.3% | 38.7% | 21.1% | 16.4% | 25.7% |
| Return on assets | 5.1% | 3.2% | 3.4% | 3.7% | 3.9% | β3.7% | 5.2% | 3.1% | 2.9% | 5.3% |
| Growth | ||||||||||
| Revenue growth | β5.5% | 5.0% | 28.2% | 4.6% | β19.5% | 21.3% | 13.6% | β7.2% | β1.7% | 4.8% |
| Net income growth | 26.2% | β34.9% | 35.9% | 16.2% | 13.5% | β196.7% | β | β38.1% | β5.8% | 74.1% |
| EPS growth | 26.2% | β33.2% | 37.8% | 15.2% | 13.8% | β200.0% | β | β37.2% | β5.6% | 79.7% |
| FCF growth | β200.8% | β | β | 608.3% | β1.4% | β88.3% | β140.5% | β | 19.6% | 41.6% |
| Share count change | 0.1% | β2.7% | β1.3% | 0.8% | β0.2% | β3.1% | β6.9% | β1.4% | β0.2% | β3.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | 3.6x | 3.5x | 2.8x | 2.6x |
| Debt / equity | β | 8.9x | 9.3x | 4.7x | 3.7x | 3.3x | 3.8x | 3.1x | 2.3x | 2.0x |
| Interest coverage | 4.1x | 4.1x | 2.9x | 2.8x | 3.6x | 5.4x | 4.7x | 2.9x | 3.1x | 3.9x |
| Current ratio | 1.0x | 1.0x | 1.0x | 1.0x | 1.2x | 1.1x | 1.2x | 1.2x | 1.2x | 1.0x |
| Quick ratio | 0.6x | 0.5x | 0.6x | 0.6x | 0.9x | 0.7x | 0.7x | 0.8x | 0.8x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.7% | 5.7% | 4.1% | 3.4% | 5.9% | 7.2% | 6.5% | 6.6% | 3.4% | 3.3% |
| Stock comp / revenue | 0.2% | 0.3% | 0.2% | 0.3% | 0.3% | 0.3% | 0.2% | 0.3% | 0.4% | 0.4% |
| Payouts / FCF | β | β | 3.7% | 0.9% | 8.7% | 1,185.4% | β | 19.2% | 42.6% | 56.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 3.0 | 3.0 | 7.0 | 4.0 | 7.0 | 4.0 | 7.0 | 4.0 | 6.0 | 7.0 |
| Altman Z'' | 1.6 | 1.6 | 1.4 | 1.8 | 1.8 | 1.8 | 1.9 | 1.8 | 2.2 | 2.0 |
| Accruals ratio | 6.4% | 5.7% | β1.0% | β4.7% | β5.0% | β9.6% | β0.5% | β6.8% | β5.3% | β5.6% |
Source: SEC EDGAR XBRL filings (CIK 0001219601). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.